STOCK TITAN

TOMI Environmental Solutions (TOMZ) Stock Price, News & Analysis

TOMZ NASDAQ
Published by Stock Titan Data refreshed

Price Move History

Daily moves over 5%
64 251 sessions, November 20, 2025 to November 20, 2026
Largest daily move
+16.2% close of May 8, 2026
1-year change
-8.2% closing prices, November 20, 2025 to November 20, 2026
1-month change
+45.5% closing prices, October 20, 2026 to November 20, 2026

Company Description

TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) is described as a global decontamination and infection prevention company that focuses on environmental solutions for indoor surface disinfection and broader disinfection and decontamination needs. The company manufactures, sells, and licenses its premier Binary Ionization Technology® (BIT™) platform, which underpins its SteraMist® brand of products. TOMI is classified in the Facilities Support Services industry within the Administrative and Support and Waste Management and Remediation Services sector.

The BIT™ solution, invented under a defense grant in association with the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense, utilizes a low percentage hydrogen peroxide as its only active ingredient. This solution is used to produce a fog of ionized Hydrogen Peroxide (iHP™), represented commercially by the SteraMist® product line. According to the company’s descriptions, iHP™ produces a germ-killing aerosol that behaves like a visual non-caustic gas, enabling high-level disinfection and decontamination of indoor environments and surfaces.

Core technology and SteraMist® platform

TOMI’s business centers on the application of its BIT™ platform through various SteraMist® systems. These systems are designed for environmental surface disinfection and decontamination, including room fogging and treatment of critical spaces. The company notes that its products are intended for a broad spectrum of commercial structures and use sites. These include hospitals and medical facilities, biosafety laboratories, pharmaceutical facilities, cruise ships, commercial and office buildings, hotel and motel rooms, schools, restaurants, meat and produce processing facilities, military barracks, police and fire departments, and athletic facilities. TOMI also states that its products and services have been used in single-family homes and multi-unit residential properties.

In addition to portable and service-based applications, TOMI highlights platforms such as the SteraMist Integrated System (SIS), Custom Engineered System (CES), and SteraMist Hybrid System. These offerings are used for automated and integrated decontamination within enclosures, sterilization rooms, and other controlled environments. For example, the company reports multi-stage SteraMist iHP implementations at cell and gene therapy manufacturing sites, integration of SteraMist iHP into passthrough fill boxes at a global biopharmaceutical company, and installation of a SteraMist Hybrid System in a sterilization room at a private research university facility.

Applications across regulated and high-risk environments

TOMI emphasizes that its technology is used in regulated industries and high-risk environments where contamination control and infection prevention are critical. The company cites applications in life sciences, pharmaceutical manufacturing, cell and gene therapy facilities, 503B compounding, medical device reprocessing, animal research environments, and healthcare-related decontamination. It also describes outreach to the cruise industry, advocating for adoption of hospital-grade disinfection technology such as SteraMist to address pathogens including Norovirus and Legionella on cruise ships.

The company positions its SteraMist iHP technology as part of contamination control strategies in facilities that must meet current Good Manufacturing Practices (cGMP) and other stringent regulatory requirements. TOMI reports that its systems are used for automated room fogging, surface treatment, and whole-facility fogging services, covering areas such as manufacturing suites, quality control laboratories, support spaces, and specialized enclosures. It also notes that its iHP Corporate Service team performs whole-facility fogging services to reset laboratory spaces to operational conditions.

Business activities and service offerings

According to company disclosures, TOMI generates business through manufacturing and sales of SteraMist equipment, recurring sales of its BIT™ solution, licensing of its technology platform, and service offerings. The company references recurring BIT™ solution sales and describes a network of distributors and service providers, including specialized providers for healthcare and mold remediation and decontamination service franchises. TOMI also reports development of standard operating procedure (SOP) packages, installation and operational qualification (IQ/OQ) packages, and performance qualification (PQ) services in connection with SteraMist system deployments.

TOMI states that it develops training programs and application protocols for clients. It also notes that it operates the SteraMist Pro Certified program, which supports the onboarding of service provider companies that use SteraMist iHP technology in their operations. Through these programs and partnerships, TOMI aims to support consistent application of its decontamination technology across various sectors.

Industry affiliations and memberships

The company reports that it is a member in good standing of several professional and industry organizations. These include The American Biological Safety Association, The American Association of Tissue Banks, the Association for Professionals in Infection Control and Epidemiology, the Society for Healthcare Epidemiology of America, the America Seed Trade Association, and The Restoration Industry Association. These affiliations reflect TOMI’s engagement with communities involved in biosafety, infection control, tissue banking, seed trade, and restoration services.

Market focus and project pipeline

TOMI highlights a focus on life sciences and medical device sectors, describing a custom integration pipeline for its SteraMist Integrated System (SIS) and Custom Engineered System (CES) platforms. The company reports active projects and a pipeline of automated installation projects involving SteraMist Hybrid, CES, and SIS platforms. It notes strategic partnerships with enclosure manufacturers such as ESCO Micro Pte. Ltd., Steelco S.p.A., Pharma Biotech System Components (PBSC), Nuaire, Inc., and Getinge AB, which facilitate integration of its iHP technology into existing enclosure systems used in regulated environments.

The company also references demand from academic institutions, animal research facilities, and decontamination service providers. It describes participation in industry events such as the American Association for Laboratory Animal Science (AALAS) National Meeting, where it showcases its SteraMist SIS platform and engages with research institutions and distributors.

Corporate and listing information

TOMI Environmental Solutions, Inc. is incorporated in Florida and lists its common stock on The Nasdaq Capital Market under the trading symbol TOMZ. In an 8-K filing, the company reports receiving deficiency letters from Nasdaq related to the minimum bid price requirement and minimum stockholders’ equity requirement for continued listing. The company states that these notifications have no immediate effect on the listing or trading of its common stock and that the stock continues to trade on The Nasdaq Capital Market under the symbol TOMZ, while it considers measures to regain compliance with Nasdaq listing rules.

In another 8-K filing, TOMI reports entering into an Equity Purchase Agreement with Hudson Global Ventures, LLC, giving the company the right, but not the obligation, to sell up to a specified amount of its common stock over a defined commitment period, subject to conditions and Nasdaq rules. The company also references plans to file a universal shelf registration statement on Form S-3 to provide flexibility to offer and sell securities up to a stated aggregate amount.

Use environments and sectors served

Across its public descriptions and news releases, TOMI identifies a range of sectors and environments where its technology is applied:

  • Hospitals and medical facilities
  • Biosafety laboratories and pharmaceutical facilities
  • Cell and gene therapy manufacturing sites and other life sciences operations
  • Cruise ships and maritime environments
  • Commercial and office buildings, hotels and motels
  • Schools and restaurants
  • Meat and produce processing facilities
  • Military barracks, police and fire departments
  • Athletic facilities
  • Single-family homes and multi-unit residences

These stated use cases position TOMI within markets where infection prevention, contamination control, and environmental decontamination are central operational concerns.

Stock Performance

$2.14
+2.34%
+0.05
Last updated: at
-8.2%
Performance 1 year
$21.4M
10.0M
Shares outstanding As of November 16, 2026.

TOMI Environmental Solutions (TOMZ) closed at $2.14 on November 20, 2026. Over the past 12 months, the price has lost 8.2%.

See what a $1,000 investment in TOMZ would be worth today

Average down calculator for TOMZ

TOMZ Metrics & Rankings

Price returns through November 20, 2026. Month and year figures include the first trading day. Ranking links may use different dates.

Latest News

TOMI Environmental Solutions has 10 recent news articles, with the latest published on . Of the recent coverage, 6 articles coincided with positive price movement and 4 with negative movement. Key topics include earnings, conferences, earnings date. View all TOMZ news →

SEC Filings

TOMI Environmental Solutions has filed 10 recent SEC filings, including 6 Form 8-K, 1 Form SCHEDULE 13G, 1 Form 10-Q, 1 Form NT 10-Q. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all TOMZ SEC filings →

Financial Highlights

TOMI Environmental Solutions generated $5.6M in revenue in FY2025, retaining a 54.6% gross margin, operating income reached -$3.9M (-68.4% operating margin), and net income was -$3.7M, reflecting a -66.5% net profit margin. Diluted earnings per share stood at -$0.57. The company generated -$1.2M in operating cash flow. The current ratio was 1.32, measuring current assets divided by current liabilities.

$5.6M
Revenue (FY2025)
-$3.7M
Net Income (FY2025)
-$1.2M
Operating Cash Flow

Upcoming Events

No upcoming events scheduled for TOMZ.

Short Interest History

Last 12 Months

Short interest in TOMI Environmental Solutions (TOMZ) currently stands at 14.9 thousand shares, down 8.9% from the previous reporting period, representing 0.2% of the float. Since the latest stock split, short interest has decreased by 64.3%, measured from August 2026.

Days to Cover History

Last 12 Months

Days to cover for TOMI Environmental Solutions (TOMZ) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume. Across the settlements charted above, it has ranged from 1.0 to 3.5 days.

TOMZ Company Profile & Sector Positioning

TOMI Environmental Solutions (TOMZ) operates in the Pollution & Treatment Controls industry within the broader Industrials sector and is listed on the NASDAQ.

Investors comparing TOMZ often look at related companies in the same sector, including Birchtech Corp. (BCHT), 374Water Inc. (SCWO), Fuel Tech, Inc. (FTEK), ClearSign Technologies Corporation (CLIR), and Rain Enhancement Technologies Holdco, Inc. (RAIN). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate TOMZ's relative position within its industry.

Frequently Asked Questions

The current stock price of TOMI Environmental Solutions (TOMZ) is $2.14 as of November 20, 2026.

The market cap of TOMI Environmental Solutions (TOMZ) is approximately $21.4M. Learn more about what market capitalization means .

The FY2025 revenue of TOMI Environmental Solutions (TOMZ) is $5.6M, from its most recent completed fiscal year.

The FY2025 net income of TOMI Environmental Solutions (TOMZ) is -$3.7M, from its most recent completed fiscal year.

The diluted earnings per share (EPS) of TOMI Environmental Solutions (TOMZ) is -$0.57 for FY2025, its most recent completed fiscal year. Learn more about EPS .

The operating cash flow of TOMI Environmental Solutions (TOMZ) is -$1.2M for FY2025, its most recent completed fiscal year. Learn about cash flow.

The net profit margin of TOMI Environmental Solutions (TOMZ) is -66.5% for FY2025, its most recent completed fiscal year. Learn about profit margins.

The operating profit margin of TOMI Environmental Solutions (TOMZ) is -68.4% for FY2025, its most recent completed fiscal year. Learn about operating margins.

The gross profit margin of TOMI Environmental Solutions (TOMZ) is 54.6% for FY2025, its most recent completed fiscal year. Learn about gross margins.

The current ratio of TOMI Environmental Solutions (TOMZ), current assets divided by current liabilities, was 1.32 at the end of FY2025, its most recent completed fiscal year. Learn about liquidity ratios.

The gross profit of TOMI Environmental Solutions (TOMZ) is $3.1M for FY2025, its most recent completed fiscal year.

The operating income of TOMI Environmental Solutions (TOMZ) is -$3.9M for FY2025, its most recent completed fiscal year. Learn about operating income.

TOMI Environmental Solutions, Inc. is described as a global decontamination and infection prevention company. It provides environmental solutions for indoor surface disinfection and broader disinfection and decontamination needs through the manufacturing, sales, and licensing of its Binary Ionization Technology (BIT) platform, represented by the SteraMist brand of products.

Binary Ionization Technology (BIT) is TOMI’s proprietary platform, invented under a defense grant in association with DARPA of the U.S. Department of Defense. The BIT solution uses a low percentage hydrogen peroxide as its only active ingredient to produce a fog of ionized Hydrogen Peroxide (iHP). According to the company, iHP produces a germ-killing aerosol that behaves like a visual non-caustic gas for disinfection and decontamination.

SteraMist is the brand under which TOMI markets systems based on its BIT and iHP technology. The company states that SteraMist products are designed for environmental surface disinfection and decontamination, including room fogging and treatment of critical spaces. SteraMist is used in settings such as hospitals, pharmaceutical facilities, biosafety labs, cruise ships, commercial buildings, schools, food processing facilities, and residential properties.

TOMI reports that its products are used in a broad spectrum of structures and use sites, including hospitals and medical facilities, biosafety laboratories, pharmaceutical facilities, cruise ships, commercial and office buildings, hotel and motel rooms, schools, restaurants, meat and produce processing facilities, military barracks, police and fire departments, athletic facilities, single-family homes, and multi-unit residences. It also highlights applications in life sciences, cell and gene therapy manufacturing, animal research environments, and healthcare-related decontamination.

TOMI describes the SteraMist Integrated System (SIS), Custom Engineered System (CES), and SteraMist Hybrid System as platforms for integrating its iHP technology into automated and custom installations. These platforms are used for applications such as automated room fogging, integrated decontamination of enclosures and passthrough systems, and dedicated sterilization rooms in facilities like pharmaceutical manufacturing sites and research universities.

The company states that it serves regulated industries where contamination control is critical, including life sciences, pharmaceutical manufacturing, and cell and gene therapy. TOMI reports providing multi-stage SteraMist iHP implementations that support contamination control strategies aligned with current Good Manufacturing Practices (cGMP). It also offers standard operating procedure (SOP) development, installation and operational qualification (IQ/OQ), and performance qualification (PQ) services for its systems.

TOMI reports that it is a member in good standing of The American Biological Safety Association, The American Association of Tissue Banks, the Association for Professionals in Infection Control and Epidemiology, the Society for Healthcare Epidemiology of America, the America Seed Trade Association, and The Restoration Industry Association.

According to an 8-K filing, TOMI Environmental Solutions, Inc. is incorporated in Florida and its common stock is listed on The Nasdaq Capital Market under the trading symbol TOMZ.

In an 8-K dated November 21, 2025, TOMI reports receiving deficiency letters from Nasdaq indicating that its common stock had traded below the minimum bid price requirement and that stockholders’ equity was below the minimum required level for continued listing. The company states that these notifications had no immediate effect on the listing or trading of its common stock and that the stock continued to trade on The Nasdaq Capital Market under the symbol TOMZ while it considered actions to regain compliance.

In an 8-K dated November 12, 2025, TOMI reports entering into an Equity Purchase Agreement with Hudson Global Ventures, LLC, giving the company the right, but not the obligation, to sell up to a specified amount of its common stock over a 24-month period, subject to conditions and Nasdaq rules. The company also states that it plans to register these issuances and sales under a registration statement and has discussed filing a universal shelf registration statement on Form S-3 to allow it to offer and sell securities up to a stated aggregate amount.

TOMI describes strategic partnerships with enclosure manufacturers such as ESCO Micro Pte. Ltd., Steelco S.p.A., Pharma Biotech System Components (PBSC), Nuaire, Inc., and Getinge AB to integrate its iHP technology into enclosure systems. It also references relationships with distributors, including Ares Scientific, and with decontamination service providers and franchises that purchase SteraMist equipment and BIT solution and participate in programs such as SteraMist Pro Certified.

In a news release, TOMI calls on cruise lines to adopt hospital-grade disinfection technology such as SteraMist to improve decontamination standards on ships. The company notes that SteraMist can be applied to public dining and entertainment areas, crew health and high-risk areas, children’s areas, onboard clinics and operating rooms, play structures, and outdoor lounge chairs to support proactive outbreak management on cruise vessels.